NEXIEN BIOPHARMA, INC. Annual Return On Assets in % from 2017 to 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Nexien Biopharma, Inc. quarterly/annual Return On Assets history and growth rate from 2017 to 2024.
  • Nexien Biopharma, Inc. Return On Assets for the quarter ending December 31, 2024 was -3.42K %, a 295% decline year-over-year.
  • Nexien Biopharma, Inc. annual Return On Assets for 2024 was -2.22K %, a 334% decline from 2023.
  • Nexien Biopharma, Inc. annual Return On Assets for 2023 was -511 %, a 43.1% increase from 2022.
  • Nexien Biopharma, Inc. annual Return On Assets for 2022 was -898 %, a 84.3% increase from 2021.
Return On Assets, Annual (%)
Return On Assets, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2024 -2.22K -1.71K -334% Jul 1, 2023 Jun 30, 2024
2023 -511 +387 +43.1% Jul 1, 2022 Jun 30, 2023
2022 -898 +4.81K +84.3% Jul 1, 2021 Jun 30, 2022
2021 -5.7K -3.53K -163% Jul 1, 2020 Jun 30, 2021
2020 -2.17K -1.59K -272% Jul 1, 2019 Jun 30, 2020
2019 -583 -442 -313% Jul 1, 2018 Jun 30, 2019
2018 -141 -130 -1162% Jul 1, 2017 Jun 30, 2018
2017 -11.2 Jul 1, 2016 Jun 30, 2017
* An asterisk sign (*) next to the value indicates that the value is likely invalid.